Table 1 Demographic and clinical characteristics
Variables | N = 27 |
|---|---|
Male, n (%) | 10 (37) |
Age, (mean ± DS) | 80.7 ± 5.2 |
Log EuroScore, (mean ± DS) | 14.9 ± 12 |
BMI, (mean ± DS) | 27.5 ± 5.5 |
Symptoms | |
Syncope, n (%) | 4 (14.8) |
Unstable Angina, n (%) | 6 (22.3) |
Hospitalization for heart failure, n (%) | 10 (37) |
Dyspnoea, n (%) | 25 (92.6) |
RiskFactors | |
Hypertension, n (%) | 23 (85.1) |
Diabetes , n (%) | 4 (14.8) |
Hypercholesterolemia, n (%) | 9 (33.3) |
Smoker, n (%) | 3 (11.1) |
Ex smoker, n (%) | 2 (7.4) |
Cirrhosis, n (%) | 1 (3.7) |
Renal failure (creatinine > 2 mg/dL), n (%) | 5 (18.5) |
COPD, n (%) | 7 (25.9) |
Chronic obstructive arterial disease, n (%) | 2 (7.4) |
Previous CABG, n (%) | 2 (7.4) |
Previous PCI, n (%) | 11 (40.7) |
Untreated obstructive CAD, n (%) | 2 (7.4) |
Previous MI, n (%) | 7 (25.9) |
Previous Stroke, n (%) | 3 (11.1) |
Class NYHA III-IV pre-TAVI, n (%) | 27 (100) |
Class NYHA III-IV post-TAVI, n (%) | 0 (0) |
Implanted valve | |
Medtronic CoreValve26 mm, n (%) | 11 (40.7) |
Medtronic CoreValve 29 mm, n (%) | 10 (37.1) |
Edwards SAPIEN 23 mm, n (%) | 1 (3.7) |
Edwards SAPIEN 26 mm, n (%) | 5 (18.5) |